KoreaBIO picks Samsung Bioepis’ Ko as presient; plus Adaptive, Omeros, Acadia, ViaCyte, Flexion, Aquestive, GreenLight  

Korea Biotechnology Industry Organization appointed Christopher Hansung Ko as the new president of the trade group. Ko is the CEO of biosimilars company Samsung Bioepis Co. Ltd.

Immune medicine platform company Adaptive Biotechnologies Corp. (NASDAQ:ADPT) said CTO Mark Adams will become COO; and that Nancy Hill, EVP, operations and program management, will leave the company effective March 2...